Frühstücksrunden

EXIST – Existenzgründungen aus der Wissenschaft

Saal: Studio Terrasse 2.1

The United States is the undisputed world leader when it comes to medical biotechnology. Receiving FDA approval for a therapy is considered a milestone in a company's development and a blueprint for growth in other markets. Likewise, providers of innovative services seek access to the world's largest healthcare market. Almost every company sooner or later faces the question of how to approach this market. Together with our experts, we will take a concise and practical look at the challenges and trends in US business. We will explore what really matters. Come and join the discussion!

Podium

Dr. Patrik Frei

Dr. Patrik Frei

Venture Valuation AG

Bradley H. Doline

Bradley H. Doline

Wilson Sonsini Goodrich & Rosati

Dr. Wolf S. Richter

Dr. Wolf S. Richter

Pharmtrace klinische Entwicklung GmbH